July 19, 2024

Cannabidiol Market Size to Grow USD 35.96 Billion by 2033

The global cannabidiol market size reached USD 8.13 billion in 2023 and is projected to rake around USD 35.96 billion by 2033 with a CAGR of 16.03% from 2024 to 2033.

Key Points

  • North America held the largest market share of 82% in 2023.
  • By source type, the hemp segment held the largest market share.
  • By sale type, the B2B segment holds the largest market share.
  • By end use, the pharmaceutical segment holds the largest market share.

Cannabidiol Market Size 2024 to 2033

The Cannabidiol (CBD) market has witnessed remarkable growth in recent years, propelled by the increasing acceptance of CBD-based products for various health and wellness applications. CBD, a non-psychoactive compound derived from the cannabis plant, has gained widespread popularity due to its potential therapeutic benefits. The market’s landscape has evolved as regulatory barriers surrounding the use of CBD have eased in several regions, leading to a surge in consumer demand and product innovation.

The global CBD market is characterized by a diverse range of products, including oils, tinctures, capsules, edibles, and topicals. This diversity has contributed to the market’s resilience and broad appeal, reaching consumers seeking alternatives for managing various health conditions, from anxiety and insomnia to chronic pain. As the market continues to expand, players are focusing on research and development to explore new applications and delivery methods, further shaping the industry’s trajectory.

Get a Sample: https://www.precedenceresearch.com/sample/3933

Growth Factors

Several factors contribute to the sustained growth of the CBD market. First and foremost is the increasing awareness and acceptance of CBD as a natural remedy for various health issues. Consumers are becoming more educated about the potential benefits of CBD, leading to a shift in perception and a growing preference for CBD-infused products. Additionally, the expanding legalization of cannabis for medical and recreational purposes in various regions has created a conducive environment for market growth.

Moreover, the growing interest of major corporations and investors in the CBD industry has provided significant impetus. Strategic partnerships, mergers, and acquisitions have become prevalent as established companies seek to capitalize on the booming CBD market. The inclusion of CBD in mainstream retail channels and the development of dedicated CBD stores further contribute to market expansion, enhancing accessibility for consumers.

Region Insights:

The global CBD market exhibits regional variations influenced by regulatory frameworks, cultural attitudes, and market maturity. North America has been a frontrunner, with the United States and Canada at the forefront of CBD adoption. The passage of the Farm Bill in the U.S., legalizing hemp cultivation, has been a game-changer, fostering a robust CBD industry. Europe follows closely, with countries like the United Kingdom, Germany, and Switzerland witnessing growing consumer interest and regulatory advancements.

Asia-Pacific, while traditionally conservative regarding cannabis, is gradually opening up to the therapeutic potential of CBD. Countries such as Japan and South Korea have seen a rise in CBD awareness, signaling potential opportunities for market players. Latin America and Africa, with their rich agricultural landscapes, present untapped potential for CBD cultivation and production, awaiting regulatory developments to unleash their market prowess.

Cannabidiol Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 16.03%
Global Market Size in 2023 USD 8.13 Billion
Global Market Size by 2033 USD 35.96 Billion
U.S. Market Size in 2023 USD 4 Billion
U.S. Market Size by 2033 USD 17.69 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Source Type, By Sales Type, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Cannabidiol Market Dynamics

Drivers:

Several key drivers fuel the continuous expansion of the CBD market. The increasing prevalence of chronic health conditions, coupled with a growing preference for natural remedies, drives consumer interest in CBD. Scientific research supporting the potential therapeutic effects of CBD, such as anti-inflammatory and neuroprotective properties, further bolsters its credibility and fosters consumer trust.

The wellness trend, emphasizing holistic health approaches, has been a significant driver, with consumers integrating CBD into their daily routines for general well-being. The emergence of novel applications, such as CBD-infused beverages and skincare products, extends the market’s reach and attracts diverse consumer demographics. Additionally, the COVID-19 pandemic has underscored the importance of mental health, leading to a surge in demand for CBD products targeting stress and anxiety management.

Restraints:

Despite its promising outlook, the CBD market faces certain challenges. Regulatory uncertainties in some regions pose obstacles to market growth, creating a fragmented landscape with varying compliance requirements. Concerns about product quality and consistency also persist, with the lack of standardized testing and labeling practices leading to consumer skepticism. Additionally, the association of CBD with the cannabis plant has resulted in lingering stigmas, hindering widespread acceptance and adoption.

Market saturation and intense competition among a multitude of CBD brands contribute to pricing pressures and potential commoditization of products. The evolving regulatory environment adds an element of unpredictability, requiring market participants to navigate complex legal frameworks and adapt to changes swiftly. These challenges underscore the need for industry collaboration and proactive measures to address regulatory concerns and build consumer confidence.

Opportunities:

Amid challenges, the CBD market is rife with opportunities for innovation and growth. The increasing trend of incorporating CBD into mainstream products, such as cosmetics, food and beverages, and pet care, opens up new market segments. The exploration of novel delivery methods, including nanotechnology and advanced formulations, enhances product efficacy and distinguishes brands in a crowded market.

International expansion presents a substantial opportunity for companies to tap into emerging markets with evolving regulatory landscapes. Collaboration with healthcare professionals and research institutions can further validate the therapeutic potential of CBD, paving the way for medical applications and pharmaceutical developments. Additionally, the rising interest in sustainable and organic products provides a platform for CBD brands to emphasize ethical practices and environmental responsibility, appealing to a conscious consumer base.

Read Also: Blood Platelets Market Size to Worth USD 9.86 Billion by 2033

Recent Developments

  • In January 2023, the NCL released a statement regarding the FDA’s decision on the CBD regulatory framework.
  • In February 2024, Avicanna reported a new supply and licensing agreement for two products.
  • In November 2022, PrograMetrix & WUNDERWORX launched a partnership to assist cannabis and CBD brands in achieving mainstream marketing success.
  • In November 2023, The CURE Brand expanded its cannabis wellness consumer products into Asia.
  • In February 2024, Curaleaf International acquired Can4Med, expanding its presence in Poland’s growing medical cannabis market.

Cannabidiol Market Companies

  • ENDOCA
  • Cannoid, LLC
  • Medical Marijuana, Inc.
  • Folium Europe B.V.
  • Canopy Growth Corporation
  • Elixinol
  • NuLeaf Naturals, LLC
  • Isodiol International, Inc.
  • PharmaHemp
  • The Cronos Group

Segments Covered in the Report

By Source Type

  • Hemp
  • Marijuana

By Sales Type

  • B2B
    • By End-use
      • Pharmaceuticals
      • Wellness
        • Food & Beverages
        • Personal Care & Cosmetics
        • Nutraceuticals
        • Others
  • B2C
    • By Sales Channel
      • Hospital Pharmacies
      • Online
      • Retail Stores

By End-use

  • Medical
    • Chronic Pain
    • Mental Disorders
    • Cancer
    • Others
  • Personal Use
  • Pharmaceuticals
  • Wellness
    • Food & Beverages
    • Personal Care & Cosmetics
    • Nutraceuticals
    • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *